Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLARITY paediatric bowel cleansing study
2025-522046-42-00Phase 3Authorised
- Sponsor
- Norgine
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 10
01
Overview
Phase 3, randomised, single-blind trial in colonic diseases comparing PLENVU with sodium picosulfate (2 arms). Primary endpoint: Success rate of bowel cleansing based on BBPS. Planned start Mar 2026; status: authorised.
02
Drugs
polyethylene glycol + electrolytes + ascorbic acidsodium picosulfate
03
Conditions
colonic diseases
Beyond the preview
Go deeper on 2025-522046-42-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522046-42-00.